The Arabidopsis Epitranscriptome

Total Page:16

File Type:pdf, Size:1020Kb

The Arabidopsis Epitranscriptome Available online at www.sciencedirect.com ScienceDirect The Arabidopsis epitranscriptome 1 2 Rupert G Fray and Gordon G Simpson The most prevalent internal modification of plant messenger for Arabidopsis embryogenesis [1], and crucial to proper 6 6 RNAs, N -methyladenosine (m A), was first discovered in the development [2]. Consequently, the control and impact 1970s, then largely forgotten. However, the impact of of an entire layer of gene regulation awaits discovery. modifications to eukaryote mRNA, collectively known as the 6 epitranscriptome, has recently attracted renewed attention. Methylating mRNA m A mRNA methylation is required for normal Arabidopsis The most prevalent internal modification of eukaryotic 6 development and the first methylation maps reveal that mRNA is methylation of adenosine at the N position 6 thousands of Arabidopsis mRNAs are methylated. Arabidopsis (m A). Although first discovered in mammalian [3,4] and is likely to be a model of wide utility in understanding the plant [5,6] mRNAs in the 1970s, it is only recently that 6 biological impacts of the epitranscriptome. We review recent m A has been mapped transcriptome-wide and that func- 6 progress and look ahead with questions awaiting answers to tions for m A have been uncovered [7 ,8 ]. reveal an entire layer of gene regulation that has until recently 6 been overlooked. Mapping m A modifications 6 Base-specific identification of m A is technically chal- Addresses 1 lenging and not yet feasible transcriptome-wide. Instead, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, Leicestershire LE12 5RD, UK the current state-of-the-art involves using antibodies that 2 6 Division of Plant Sciences, College of Life Sciences, University of recognize m A to immunoprecipitate and then sequence Dundee, Cell and Molecular Sciences, James Hutton Institute, RNAs carrying this modification in a procedure known as Invergowrie DD2 5DA, Scotland, UK 6 MeRIP-Seq [9]. Because the specificity of anti-m A antibodies is variable, such experiments should ideally Corresponding authors: Fray, Rupert G ([email protected]) and Simpson, Gordon G ([email protected]) be controlled for by sequencing genetic backgrounds defective in mRNA methylation [10 ], and possibly in conjunction with cross-linking of the methylating Current Opinion in Plant Biology 2015, 27:17–21 enzymes to reference the directness of the reactions This review comes from a themed issue on Cell signalling and gene involved. regulation 6 0 Edited by Xiaofeng Cao and Blake C Meyers m A is mostly associated with the 3 end of Arabidopsis mRNA transcripts (within 150 nt of the poly(A) tail) [2]. For a complete overview see the Issue and the Editorial Subsequent MeRIP-Seq transcriptome-wide mapping Available online 3rd June 2015 studies with yeast, human and Arabidopsis mRNA con- http://dx.doi.org/10.1016/j.pbi.2015.05.015 firm this phenomenon, revealing a peak of methylation in 0 # 1369-5266/ 2015 The Authors. Published by Elsevier Ltd. This is an 3 UTRs and over the stop codon [10 ,11,12 ]. A consen- open access article under the CC BY license (http://creativecommons. sus methylation target sequence closely related to that org/licenses/by/4.0/). derived for human data of (G/A)(G/A)ACU, is found in different eukaryotes and is consistent with a previously established methylation motif identified by in vitro en- The Arabidopsis genome: from both sides zyme activity, RNAse fragmentation and labelling stud- now? ies [13], and by direct biochemical mapping of sites in The landmark sequencing of the Arabidopsis thaliana Rous sarcoma virus and bovine prolactin transcripts (Arabidopsis) genome in 2000, still leaves us asking what [14,15]. the genome really encodes? Subsequent sequencing of 0 6 Arabidopsis RNAs reveals alternative transcription start Although enriched in 3 UTRs, m A is found throughout sites, alternative splicing and alternative sites of cleavage mRNAs, including intronic sequences, indicating the and polyadenylation of RNAs transcribed from the same modification may be added co-transcriptionally [16]. It locus. The more we sequence in different genotypes, cell- is not yet known whether nascent transcripts are more types and situations, the more evidence of alternative widely methylated and then subsequently demethylated 0 processing we detect, and the more non-protein-coding in specific regions. In addition to the 3 enrichment, RNAs of unknown function we find. But that’s not all. Arabidopsis MeRIP-Seq data indicates an increased 6 0 Although we have sequenced from both sides now, DNA abundance of m A at the 5 end of some transcripts. 6 and RNA, the modifications of mRNA, known as the However, an association of m A with long exons that epitranscriptome, have been almost completely over- has been found in mammalian mRNA was not reported in looked. Yet we know mRNA methylation is essential the first Arabidopsis MeRIP-Seq data [12 ]. www.sciencedirect.com Current Opinion in Plant Biology 2015, 27:17–21 18 Cell signalling and gene regulation Figure 1 Pre-mRNA processing Nuclear export mRNA stability Interpreters mRNA Localization Translation efficiency YTH Readers 6 7Gppp GGm ACU AAAAAAAAAAAAAA N N N N N MTB? H CH3 Writers ? MTA FIP37 H H AlkB N Erasers ? N N Other Modifications ? N N 7Gppp GGACU AAAAAAAAAAAAAA Current Opinion in Plant Biology 6 The Arabidopsis epitranscriptome. The most prevalent internal modification of eukaryote mRNA is methylation of adenosine at the N position. 6 0 Although m A is found throughout mRNA it is enriched towards the 3 end of Arabidopsis mRNAs. This code is written by a writer complex comprised of MTA, FIP37 and probably other proteins that likely include a protein closely related to MTA called MTB. In humans this modification is apparently reversible through the action of AlkB family proteins. Although related AlkB family proteins exist in Arabidopsis, there is no evidence 6 yet that they are involved in this process. m A is read by YTH domain proteins, but the combination of direct and indirect influences on RNP composition and structure determine mRNA fate. Other modifications to Arabidopsis mRNA likely remain to be discovered. It is clear that mRNA transcribed from thousands of functional methylation complexes [17–19]. MTA and Arabidopsis genes is methylated, but due to the limita- FIP37 are predominantly nuclear localized [1], indicat- 6 tions of MeRIP-Seq, the best peak-calling data corre- ing that m A modification takes place in the nucleus. spond to the most abundant RNA transcripts. Further However, the possibility that some methylation of Arabidopsis MeRIP-Seq studies and alternative valida- mRNA might occur in the cytoplasm cannot be ruled tion approaches will be needed to help clarify the RNA out at this stage. The exact composition of the writer methylome. complexes, their regulation and the degree of conser- vation remains to be determined. It is clear that not 6 Writing m A all mRNAs are methylated and not all potential con- The Arabidopsis enzyme MTA (TAIR: At4g10760) is sensus target sites are methylated either. However, the 6 required for mRNA methylation [1]. Null mutant alleles mechanistic or regulatory basis of m A selectivity is 6 are embryo lethal, indicating that mRNA m A is essential unknown. for plant survival [1]. Expressing MTA under the control 6 of the largely embryo-specific ABI3 promoter rescues Reading and interpreting m A 6 lethality of null mta mutants and the plants go on to m A can directly influence the stability or conformation of 6 complete seed-set [2]. m A levels in these plants are RNA in the absence of RNA binding proteins [20]. In 6 reduced to 5–15% levels of wild-type, confirming the addition, m A can be ‘read’ directly by YTH domain 6 requirement for this enzyme to methylate mRNA m A. containing proteins that bind this modification specifical- ly [21 ]. There are 13 Arabidopsis genes predicted to It seems likely that a conserved complex of proteins encode YTH domain containing proteins, but their func- 6 mediates m A mRNA methylation in different eukar- tions are almost wholly uncharacterized [22,23]. Structur- yotes. MTA interacts with FIP37 in plants [1], and al analyses indicate that a cage of aromatic amino acids in 6 subsequently, the interaction of the human (METTL3 the YTH domain binds m A [24,25]. Notably, the corre- and Wilm’s Tumor Associated Protein, WTAP, respec- sponding aromatic residues are conserved in each pre- tively) and yeast (IME4 and Mum2 respectively) homo- dicted Arabidopsis YTH domain protein, suggesting 6 logs have been shown to be integral to the formation of that they have the potential to bind m A. Transcripts Current Opinion in Plant Biology 2015, 27:17–21 www.sciencedirect.com The Arabidopsis epitranscriptome Fray and Simpson 19 encoding Arabidopsis YTH domain proteins show dis- Interestingly AlkB proteins with a demonstrated prefer- tinct developmental expression patterns and responses to ence for RNA substrates are encoded in some viruses that abiotic and biotic stresses [23]. infect plants [36]. Although these enzymes may function to repair the RNA genomes of these viruses, an untested One Arabidopsis YTH domain protein is relatively well possibility is that they may target host mRNAs during characterised: the Arabidopsis homologue of mRNA infection. The interplay between the epitranscriptome Cleavage and Polyadenylation Specificity Factor 30 and pathogen interactions is unexplored (Figure 1). (CPSF30) [26 ]. It has recently been shown in mammali- 6 an cells that CPSF30 plays a crucial role in cleavage and The dynamic nature of m A methylation 6 polyadenylation because together with WDR33 it appears If m A is regulatory, one might expect it to be dynamic. to be involved in binding to and selecting the poly(A) There is so far insufficient data to know if this is the case 6 signal AAUAAA [27,28].
Recommended publications
  • The Impact of Epitranscriptomic Marks on Post-Transcriptional Regulation in Plants
    Briefings in Functional Genomics, 00(00), 2020, 1–12 doi: 10.1093/bfgp/elaa021 Review Paper Downloaded from https://academic.oup.com/bfg/advance-article/doi/10.1093/bfgp/elaa021/6020141 by University of Pennsylvania Libraries user on 04 December 2020 The impact of epitranscriptomic marks on post-transcriptional regulation in plants Xiang Yu †, Bishwas Sharma† and Brian D. Gregory Corresponding author: Brian D. Gregory, Department of Biology, University of Pennsylvania, 433 S. University Ave., Philadelphia, PA 19104, USA. Tel.: +1 (215) 746-4398; Fax: +1 (215) 898-8780; E-mail: [email protected] Abstract Ribonucleotides within the various RNA molecules in eukaryotes are marked with more than 160 distinct covalent chemical modifications. These modifications include those that occur internally in messenger RNA (mRNA) molecules such as N6-methyladenosine (m6A) and 5-methylcytosine (m5C), as well as those that occur at the ends of the modified RNAs like + the non-canonical 5 end nicotinamide adenine dinucleotide (NAD ) cap modification of specific mRNAs. Recent findings have revealed that covalent RNA modifications can impact the secondary structure, translatability, functionality, stability and degradation of the RNA molecules in which they are included. Many of these covalent RNA additions have also been found to be dynamically added and removed through writer and eraser complexes, respectively, providing a new layer of epitranscriptome-mediated post-transcriptional regulation that regulates RNA quality and quantity in eukaryotic transcriptomes. Thus, it is not surprising that the regulation of RNA fate mediated by these epitranscriptomic marks has been demonstrated to have widespread effects on plant development and the responses of these organisms to abiotic and biotic stresses.
    [Show full text]
  • The Chloroplast Epitranscriptome: Factors, Sites, Regulation, and Detection Methods
    G C A T T A C G G C A T genes Review The Chloroplast Epitranscriptome: Factors, Sites, Regulation, and Detection Methods Nikolay Manavski 1,† , Alexandre Vicente 1,†, Wei Chi 2 and Jörg Meurer 1,* 1 Plant Molecular Biology, Faculty of Biology, Ludwig-Maximilians-University Munich, Großhaderner Street 2-4, 82152 Planegg-Martinsried, Germany; [email protected] (N.M.); [email protected] (A.V.) 2 Photosynthesis Research Center, Key Laboratory of Photobiology, Institute of Botany, Chinese Academy of Sciences, Beijing 100093, China; [email protected] * Correspondence: [email protected]; Tel.: +49-89-218074556 † Both authors contributed equally to this work. Abstract: Modifications in nucleic acids are present in all three domains of life. More than 170 dis- tinct chemical modifications have been reported in cellular RNAs to date. Collectively termed as epitranscriptome, these RNA modifications are often dynamic and involve distinct regulatory pro- teins that install, remove, and interpret these marks in a site-specific manner. Covalent nucleotide modifications-such as methylations at diverse positions in the bases, polyuridylation, and pseu- douridylation and many others impact various events in the lifecycle of an RNA such as folding, localization, processing, stability, ribosome assembly, and translational processes and are thus cru- cial regulators of the RNA metabolism. In plants, the nuclear/cytoplasmic epitranscriptome plays important roles in a wide range of biological processes, such as organ development, viral infection, and physiological means. Notably, recent transcriptome-wide analyses have also revealed novel dynamic modifications not only in plant nuclear/cytoplasmic RNAs related to photosynthesis but Citation: Manavski, N.; Vicente, A.; especially in chloroplast mRNAs, suggesting important and hitherto undefined regulatory steps in Chi, W.; Meurer, J.
    [Show full text]
  • Epitranscriptomics: a New Layer of Microrna Regulation in Cancer
    cancers Review Epitranscriptomics: A New Layer of microRNA Regulation in Cancer Veronica De Paolis †, Elisa Lorefice †, Elisa Orecchini, Claudia Carissimi * , Ilaria Laudadio * and Valerio Fulci Dipartimento di Medicina Molecolare, Sapienza Università di Roma, 00161 Rome, Italy; [email protected] (V.D.P.); elisa.lorefi[email protected] (E.L.); [email protected] (E.O.); [email protected] (V.F.) * Correspondence: [email protected] (C.C.); [email protected] (I.L.) † These authors contributed equally to this work. Simple Summary: MicroRNAs are small non-coding RNAs, acting as post-transcriptional regulators of gene expression. In the last two decades, their role in cancer as oncogenes (oncomir), as well as tumor suppressors, has been extensively demonstrated. Recently, epitranscriptomics, namely the study of RNA modifications, has emerged as a new field of great interest, being an additional layer in the regulation of gene expression. Almost all classes of eukaryotic RNAs, including miRNAs, undergo epitranscriptomic modifications. Alterations of RNA modification pathways have been described for many diseases—in particular, in the context of malignancies. Here, we reviewed the current knowledge on the potential link between epitranscriptomic modifications of miRNAs and cancer. Abstract: MicroRNAs are pervasive regulators of gene expression at the post-transcriptional level in metazoan, playing key roles in several physiological and pathological processes. Accordingly, these Citation: De Paolis, V.; Lorefice, E.; small non-coding RNAs are also involved in cancer development and progression. Furthermore, Orecchini, E.; Carissimi, C.; Laudadio, miRNAs represent valuable diagnostic and prognostic biomarkers in malignancies. In the last twenty I.; Fulci, V. Epitranscriptomics: A years, the role of RNA modifications in fine-tuning gene expressions at several levels has been New Layer of microRNA Regulation unraveled.
    [Show full text]
  • The Epitranscriptome of Noncoding Rnas in Cancer
    Published OnlineFirst March 20, 2017; DOI: 10.1158/2159-8290.CD-16-1292 MINI REVIEW The Epitranscriptome of Noncoding RNAs in Cancer Manel Esteller 1 , 2 , 3 and Pier Paolo Pandolfi 4 ABSTRACT The activity of RNA is controlled by different types of post-transcriptional modi- fi cations, such as the addition of methyl groups and other chemical and structural changes, that have been recently described in human cells by high-throughput sequencing. Herein, we will discuss how the so-called epitranscriptome is disrupted in cancer and what the contribution of its writers, readers, and erasers to the process of cellular transformation is, particularly focusing on the epigenetic modifi cations of ncRNAs. Signifi cance: Chemical modifi cations of RNA play a central role in the control of messenger and ncRNA activity and, thus, are tightly regulated in cells. In this review, we provide insight into how these marks are altered in cancer cells and how this knowledge can be translated to the clinical setting. Cancer Discov; 7(4); 359–68. ©2017 AACR. AN INTRODUCTION TO RNA MODIFICATIONS adenine methylation ( 2 ), DNA seems to have a smaller reper- toire of modifi ed nucleotides. RNA molecules can show All life forms need mechanisms to regulate RNA levels a more diverse spectrum of modifi cations that includes, and activities. An important part of these control belts for among others, pseudouridine or a hypermodifi ed 7-deaza- RNA occurs at the transcriptional level, but it is becom- guanosine (queuosine). ing apparent that a signifi cant part of RNA homeostasis From an academic standpoint, the RNA modifi cations can depends on RNA stability and degradation.
    [Show full text]
  • The Epitranscriptome in Stem Cell Biology and Neural Development
    Neurobiology of Disease 146 (2020) 105139 Contents lists available at ScienceDirect Neurobiology of Disease journal homepage: www.elsevier.com/locate/ynbdi Review The epitranscriptome in stem cell biology and neural development T ⁎ Caroline Vissersa,b, Aniketa Sinhab, Guo-li Mingc,d,e,f, Hongjun Songc,d,e,g, a Biochemistry, Cellular and Molecular Biology Program, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA b Department of Biochemistry and Biophysics, Department of Psychiatry, University of California at San Francisco, San Francisco, CA 94158, USA c Department of Neuroscience and Mahoney Institute for Neurosciences, Perelman School for Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA d Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA e Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA f Department of Psychiatry, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA g The Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA ARTICLE INFO ABSTRACT Keywords: The blossoming field of epitranscriptomics has recently garnered attention across many fields by findings that Epitranscriptome chemical modifications on RNA have immense biological consequences. Methylation of nucleotides inRNA, m6A 6 6 1 including N6-methyladenosine (m A), 2-O-dimethyladenosine (m Am), N1-methyladenosine (m A), 5-methyl- Stem cells cytosine (m5C), and isomerization of uracil to pseudouridine (Ψ), have the potential to alter RNA processing Brain development events and contribute to developmental processes and different diseases. Though the abundance and roles of Brain disorders some RNA modifications remain contentious, the epitranscriptome is thought to be especially relevant instem cell biology and neurobiology.
    [Show full text]
  • Association of N6-Methyladenosine with Viruses and Related Diseases Fang Wu1,2, Wenzhao Cheng1,3*, Feiyuan Zhao1,2, Mingqing Tang1,4,2, Yong Diao2 and Ruian Xu1,4,2*
    Wu et al. Virology Journal (2019) 16:133 https://doi.org/10.1186/s12985-019-1236-3 REVIEW Open Access Association of N6-methyladenosine with viruses and related diseases Fang Wu1,2, Wenzhao Cheng1,3*, Feiyuan Zhao1,2, Mingqing Tang1,4,2, Yong Diao2 and Ruian Xu1,4,2* Abstract Background: N6-methyladenosine (m6A) modification is the most prevalent internal modification of eukaryotic mRNA modulating gene expression. m6A modification is a dynamic reversible process regulated by three protein groups: methyltransferases (writers), demethylases (erasers), and m6A-binding proteins (readers). m6A modification is involved in all phases of RNA metabolism, including RNA folding, stability, splicing, nuclear exporting, translational modulation and degradation. Main body: In recent years, numerous studies have reported that abnormal m6A modification causes aberrant expression of important viral genes. Herein, we review the role of m6A in viral lifecycle and its contribution to the pathogenesis of human diseases. Particularly, we focus on the viruses associated with human diseases such as HIV- 1, IAV, HBV, HCV, EBV and many others. Conclusions: A better understanding of m6A-virus relationship would provide new insights into the viral replication process and pathogenesis of human diseases caused by viruses. In addition, exploration of the role of m6A in disease-causing viruses will reveal novel approaches for the treatment of such diseases. Keywords: N6-methyladenosine (m6A), Methyltransferases, Demethylases, m6A-binding proteins, Viral diseases Background codons, 5’untranslated region (5’UTR) and 3’untranslated Like histone and DNA, RNA undergoes covalent modifica- region (3’UTR) [7–9]. tions that fine-tunes its function [1]. Post-transcriptional m6A modification is dynamically and reversibly regu- modification of RNA is very common in eukaryotes, with lated by methyltransferases (writers) [10, 11], and re- more than one hundred types of RNA modification reported moved by demethylases (erasers) [12]; in addition, it so far [2].
    [Show full text]
  • Chemical RNA Modifications: the Plant Epitranscriptome Celso Gaspar Litholdo, Cécile Bousquet-Antonelli
    Chemical RNA Modifications: The Plant Epitranscriptome Celso Gaspar Litholdo, Cécile Bousquet-Antonelli To cite this version: Celso Gaspar Litholdo, Cécile Bousquet-Antonelli. Chemical RNA Modifications: The Plant Epitran- scriptome. Epigenetics in Plants of Agronomic Importance: Fundamentals and Applications, Springer International Publishing, pp.291-310, 2019, 10.1007/978-3-030-14760-0_11. hal-02125075 HAL Id: hal-02125075 https://hal-univ-perp.archives-ouvertes.fr/hal-02125075 Submitted on 19 Dec 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Chapter 11 1 Chemical RNA Modifications: The Plant 2 Epitranscriptome 3 Celso Gaspar Litholdo Jr and Cécile Bousquet-Antonelli 4 Abstract RNA post-transcriptional modifications create an additional layer to 5 control mRNA transcription, fate, and expression. Considering that they are non-­ 6 genetically encoded, can be of reversible nature, and involved in fine-tuning gene 7 expression, the landscape of RNA modifications has been coined the “RNA epig- 8 enome” or “epitranscriptome.” Our knowledge of the plant epitranscriptome is so 9 far limited to 3′-uridylation and internal m6A and m5C modifications in 10 Arabidopsis. m6A is the most abundant and well-studied modification on mRNAs, 11 and involves the activities of evolutionarily conserved “writer” (methyltransfer- 12 ase), “reader” (RNA binding proteins), and “eraser” (demethylases) proteins.
    [Show full text]
  • After the Epigenome: the Epitranscriptome 22 March 2017
    After the epigenome: The epitranscriptome 22 March 2017 and Professor of Genetics at the University of Barcelona, explains that this RNA also has its own spelling and grammar, just like DNA. These "epigenetics of RNA" are called epitranscriptome. "It is well-known that sometimes DNA produces a RNA string but then this RNA does not originate the protein. Because in these cases the alteration is neither in the genome nor the proteome, we thought it should be in the transcriptome, that is, in the RNA molecule", Dr. Esteller explains."In recent years, we discovered that our RNA is highly regulated and if only two or three modifications at the DNA level can control it, there may be hundreds of small changes in RNA that control its stability, its intracellular localization or its maturation in living Chemical modifications of nucleic acids constitute the beings". Epigenome (DNA) and the Epitranscriptome (RNA), which regulate the activity of the Genome. Credit: In human cells, this field did not start to be studied IDIBELL in depth in the last five years. "For example, we now know that RNA can be methylated just like DNA and in a highly specific way", says Dr. Manel Esteller, "and even more recently we observed that Our genome is made up of 6,000 million pieces of these epigenetic modifications of RNA may be key DNA that combine four "flavors": A, C, G and T in the regulation of "guardian" RNAs, also called (Adenine, Cytosine, Guanine and Thymine). It is non-coding RNAs". our Alphabet. But to this base we must add some regulation, just like the spelling and grammar of The article also points out that the epitranscriptome that alphabet: this is what we call Epigenetics.
    [Show full text]
  • Mrna and Trna Modifications As the Two Sides of the Same Coin?
    REVIEW ARTICLE The epitranscriptome in translation regulation: mRNA and tRNA modifications as the two sides of the same coin? Namit Ranjan1 and Sebastian A. Leidel2,3 1 Department of Physical Biochemistry, Max Planck Institute for Biophysical Chemistry, Goettingen, Germany 2 Max Planck Research Group for RNA Biology, Max Planck Institute for Molecular Biomedicine, Munster,€ Germany 3 Department of Chemistry and Biochemistry, University of Bern, Bern, Switzerland Correspondence Translation of mRNA is a highly regulated process that is tightly coordinated N. Ranjan, Department of Physical with cotranslational protein maturation. Recently, mRNA modifications and Biochemistry, Max Planck Institute for tRNA modifications – the so called epitranscriptome – have added a new Biophysical Chemistry, Goettingen, layer of regulation that is still poorly understood. Both types of modifications Germany – Tel: +49 5512012958 can affect codon anticodon interactions, thereby affecting mRNA translation E-mail: [email protected] and protein synthesis in similar ways. Here, we describe an updated view on S. A. Leidel, Department of Chemistry and how the different types of modifications can be mapped, how they affect Biochemistry, University of Bern, translation, how they trigger phenotypes and discuss how the combined action Bern, Switzerland of mRNA and tRNA modifications coordinate translation in health and Tel: +41 316314296 disease. E-mail: [email protected] (Received 2 April 2019, revised 7 June Keywords: disease; epitranscriptome; post-transcriptional modifications; 2019, accepted 11 June 2019, available ribosome; RNA modification; RNA sequencing; translation online 27 June 2019) doi:10.1002/1873-3468.13491 Edited by Maria Papatriantafyllou Protein synthesis is essential to life. Thus, it is regulated ribosome during protein synthesis, proteins begin to by a variety of sophisticated mechanisms and comprises fold into their final three-dimensional structure and four phases: (a) initiation; (b) elongation; (c) termina- acquire protein modifications [2].
    [Show full text]
  • An Emerging Role for Isomirs and the Microrna Epitranscriptome in Neovascularization
    cells Review An Emerging Role for isomiRs and the microRNA Epitranscriptome in Neovascularization Reginald V.C.T. van der Kwast 1, Paul H.A. Quax 1 and A. Yaël Nossent 1,2,* 1 Department of Surgery and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands; [email protected] (R.V.C.T.v.d.K.); [email protected] (P.H.A.Q.) 2 Department of Laboratory Medicine and Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria * Correspondence: [email protected] Received: 29 November 2019; Accepted: 21 December 2019; Published: 25 December 2019 Abstract: Therapeutic neovascularization can facilitate blood flow recovery in patients with ischemic cardiovascular disease, the leading cause of death worldwide. Neovascularization encompasses both angiogenesis, the sprouting of new capillaries from existing vessels, and arteriogenesis, the maturation of preexisting collateral arterioles into fully functional arteries. Both angiogenesis and arteriogenesis are highly multifactorial processes that require a multifactorial regulator to be stimulated simultaneously. MicroRNAs can regulate both angiogenesis and arteriogenesis due to their ability to modulate expression of many genes simultaneously. Recent studies have revealed that many microRNAs have variants with altered terminal sequences, known as isomiRs. Additionally, endogenous microRNAs have been identified that carry biochemically modified nucleotides, revealing a dynamic microRNA epitranscriptome. Both types of microRNA alterations were shown to be dynamically regulated in response to ischemia and are able to influence neovascularization by affecting the microRNA’s biogenesis, or even its silencing activity. Therefore, these novel regulatory layers influence microRNA functioning and could provide new opportunities to stimulate neovascularization.
    [Show full text]
  • The Regulation of RNA Modification Systems: the Next Frontier in Epitranscriptomics?
    G C A T T A C G G C A T genes Perspective The Regulation of RNA Modification Systems: The Next Frontier in Epitranscriptomics? Matthias R. Schaefer Centre for Anatomy & Cell Biology, Division of Cell-and Developmental Biology, Medical University of Vienna, Schwarzspanierstrasse 17, Haus C, 1st Floor, 1090 Vienna, Austria; [email protected]; Tel.: +43-1-40160-37702 Abstract: RNA modifications, long considered to be molecular curiosities embellishing just abundant and non-coding RNAs, have now moved into the focus of both academic and applied research. Dedicated research efforts (epitranscriptomics) aim at deciphering the underlying principles by determining RNA modification landscapes and investigating the molecular mechanisms that es- tablish, interpret and modulate the information potential of RNA beyond the combination of four canonical nucleotides. This has resulted in mapping various epitranscriptomes at high resolution and in cataloguing the effects caused by aberrant RNA modification circuitry. While the scope of the obtained insights has been complex and exciting, most of current epitranscriptomics appears to be stuck in the process of producing data, with very few efforts to disentangle cause from consequence when studying a specific RNA modification system. This article discusses various knowledge gaps in this field with the aim to raise one specific question: how are the enzymes regulated that dynami- cally install and modify RNA modifications? Furthermore, various technologies will be highlighted whose development and use might allow identifying specific and context-dependent regulators of epitranscriptomic mechanisms. Given the complexity of individual epitranscriptomes, determining their regulatory principles will become crucially important, especially when aiming at modifying specific aspects of an epitranscriptome both for experimental and, potentially, therapeutic purposes.
    [Show full text]
  • Enabling Exploration of the Eukaryotic Epitranscriptome (E4)
    Title of proposed program: Enabling Exploration of the Eukaryotic Epitranscriptome (E4) What is the major obstacle/challenge/opportunity that the Common Fund should address? Chemical modifications play a crucial role in the regulation of biological processes. For example, the function of a protein is often modulated by its stable tagging with different chemical groups, such as phosphates, sugars, or lipids, while specific chemical marks made along the chromatin (i.e., the DNA and/or its packaging proteins) can dial gene expression up or down. One area that lags behind most others in this context is the systematic characterization of all the chemical modifications that can befall RNA molecules (both coding and non-coding), sometimes referred to as the “epitranscriptome” (Saletore et al. Genome Biol. 13:175 (2012). A few covalent RNA modifications, such as 5’mRNA capping, alternative splicing, and polyadenylation, have been studied extensively. However, the functional roles of many other covalent RNA modifications remain unknown although they are likely to influence important parameters affecting RNA function, such as its stability, trafficking, localization, enzymatic/sensing/regulatory activity, and patterns of interactions with other molecules. The RNA Modification Database indicates that there are at least 65 RNA modifications that occur in eukaryotic cells (Cantara et al., 2011, Nucl. Acids Res. 39:D195-201). Transfer and ribosomal RNA can be heavily modified and some of these modifications can also occur in messenger RNA. For example, recent studies have identified N6-methyladenosine sites in thousands of human mRNAs and suggest that this modification may play a role in regulation of alternative splicing and gene expression (Dominissini et al, 2012, Nature 485:201-6; Meyer et al., 2012, Cell 149:1635-1646).
    [Show full text]